Skip to main content

Peer Review reports

From: Rapid response of stage IV colorectal cancer with APC/TP53/KRAS mutations to FOLFIRI and Bevacizumab combination chemotherapy: a case report of use of liquid biopsy

Original Submission
4 Jun 2019 Submitted Original manuscript
4 Oct 2019 Reviewed Reviewer Report - Kent Lai
8 Oct 2019 Reviewed Reviewer Report - Yaqin Wang
13 Nov 2019 Author responded Author comments - Alexander Hendricks
Resubmission - Version 2
13 Nov 2019 Submitted Manuscript version 2
25 Nov 2019 Author responded Author comments - Alexander Hendricks
Resubmission - Version 3
25 Nov 2019 Submitted Manuscript version 3
10 Dec 2019 Author responded Author comments - Alexander Hendricks
Resubmission - Version 4
10 Dec 2019 Submitted Manuscript version 4
20 Dec 2019 Author responded Author comments - Alexander Hendricks
Resubmission - Version 5
20 Dec 2019 Submitted Manuscript version 5
Publishing
23 Dec 2019 Editorially accepted
3 Jan 2020 Article published 10.1186/s12881-019-0941-5

You can find further information about peer review here.

Back to article page